Prime-boost vaccine regimen confers protective immunity to human-derived enterotoxigenic Escherichia coli (2005)
- Authors:
- Autor USP: FERREIRA, LUIS CARLOS DE SOUZA - ICB
- Unidade: ICB
- DOI: 10.1016/j.vaccine.2004.11.026
- Assunto: MICROBIOLOGIA
- Language: Inglês
- Imprenta:
- Publisher place: Kidlington
- Date published: 2005
- Source:
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
LASARO, M. O. et al. Prime-boost vaccine regimen confers protective immunity to human-derived enterotoxigenic Escherichia coli. Vaccine, v. 23, p. 2430-2438, 2005Tradução . . Disponível em: https://doi.org/10.1016/j.vaccine.2004.11.026. Acesso em: 20 jan. 2026. -
APA
Lasaro, M. O., Luiz, W. B., Sbrogio-Almeida, M. E., & Ferreira, L. C. de S. (2005). Prime-boost vaccine regimen confers protective immunity to human-derived enterotoxigenic Escherichia coli. Vaccine, 23, 2430-2438. doi:10.1016/j.vaccine.2004.11.026 -
NLM
Lasaro MO, Luiz WB, Sbrogio-Almeida ME, Ferreira LC de S. Prime-boost vaccine regimen confers protective immunity to human-derived enterotoxigenic Escherichia coli [Internet]. Vaccine. 2005 ; 23 2430-2438.[citado 2026 jan. 20 ] Available from: https://doi.org/10.1016/j.vaccine.2004.11.026 -
Vancouver
Lasaro MO, Luiz WB, Sbrogio-Almeida ME, Ferreira LC de S. Prime-boost vaccine regimen confers protective immunity to human-derived enterotoxigenic Escherichia coli [Internet]. Vaccine. 2005 ; 23 2430-2438.[citado 2026 jan. 20 ] Available from: https://doi.org/10.1016/j.vaccine.2004.11.026 - Bacillus subtilis e vacinas: avanços na pesquisa de veículos vacinais baseados em linhagens geneticamente modificadas de B. subtilis
- Functional and immunological characterization ofa natural polymorphic variantofa heat-labile toxin(LT-I)produced by enterotoxigenicEscherichia coli (ETEC)
- Protective immunity to DENV2 after immunization with a recombinant NS1 protein using a genetically detoxified heat-labile toxin as an adjuvant
- Effect of gender on training-induced vascular remodeling in SHR
- A therapeutic Her2/neu vaccine targeting dendritic cells preferentially inhibits the growth of low Her2/neu–expressing tumor in HLA-A2 transgenic mice
- Biosensor-based selective detection of Zika virus specific antibodies in infected individuals
- Immunomodulatory properties of the enterotoxigenic Escherichia coli type IIa heat-labile enterotoxin (LT-IIa) in mice immunized via the intradermal route
- Study of the natural diversity of heat-labile toxins (LT) produced by enterotoxigenic escherichia coli (ETEC) strains human-derived as an approach for the discovery of new vaccine adjuvants
- Vaccine development using live Salmonella enterica SV typhimurium strains deleted in flagellin -encoding genes using lambda red recombination approach
- Anti-tumor DNA vaccines based on the expression of human papillomavirus-16 E6/E7 oncoproteins genetically fused with the glycoprotein D from herpes simplex virus-1
Informações sobre o DOI: 10.1016/j.vaccine.2004.11.026 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
